bio CMO
Scope
Date
~
-
Bio & Pharma
LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn
South Korean pharmaceutical firm LegoChem Biosciences Inc. said on Dec. 23 it has transferred the antibody-drug conjugates (ADC) technology platform...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Bigsome Bio signs tech transfer agreement with university
Bigsome Bio, a subsidiary of Lotte Chilsung Beverage, has begun research on functional materials for respiratory health.The company said on Friday t...
Dec 20, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea's 2021 bio sector output $15.4 bn; 5-year annual growth 20%
South Korea's bio industry last year exceeded 20 trillion won ($15.4 billion) in production for the first time and continues to see strong growth.Th...
Dec 15, 2022 (Gmt+09:00)
-
Food & Beverage
Korea's CJ CheilJedang mulls rebrand with name change
South Korean food giant CJ CheilJedang Corp. is considering a new name for the company in a bid to represent its main businesses and target global c...
Dec 07, 2022 (Gmt+09:00)
-
Companies
SK Discovery launches bio strategy, investment division
Korea's chemical company SK Discovery Co. on Tuesday said it launched a bio strategy and investment division headed by Kim Jung-hoon, director of SK...
Dec 06, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharmaceutical relocates US research center from Seattle to Boston
JW Pharmaceutical announced on Wednesday that it has relocated its US research center to Boston from San Diego. JW Theriac was first establishe...
Nov 23, 2022 (Gmt+09:00)
-
Earnings
Celltrion's Q3 earnings boosted by Remsima sales in Europe
South Korean biopharmaceutical giant Celltrion Inc. announced 654.6 billion won ($478.2 million) in revenue and 213.8 billion won in operating profi...
Nov 09, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ CheilJedang to strengthen R&D for bio and healthcare businesses
CJ Corp. announced it will strengthen its research and development (R&D) efforts in the bio and healthcare sectors. CJ CheilJedang Corp. ...
Nov 08, 2022 (Gmt+09:00)
-
Bio & Pharma
Making the safest bio-based personal care material
BJ Biochem Inc. is a startup that develops various differentiated materials in the preservatives, disinfectants and surface active agent (surfactant...
Nov 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea’s Peak Bio makes Nasdaq debut via SPAC deal with Ignyte
Peak Bio Co., a South Korean biopharmaceutical company, is debuting on the Nasdaq through a merger with US blank cheque company Ignyte Acquisition C...
Oct 28, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Carlyle, GS Group to buy Korean dental scanner maker
US private equity giant The Carlyle Group and South Korean energy-to-retail conglomerate GS Group will acquire Medit Corp., the world’s third-...
Oct 25, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea's Samsung Biologics signs $296 mn CMO deal with GSK
South Korea’s Samsung Biologics Co. has signed a $296.1 million deal to supply biopharmaceutical products to UK-based multinational pharma gia...
Oct 21, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean bio suffers as weak won lifts global clinical trial costs
South Korean biopharmaceutical firms are facing challenges in clinical trials overseas alongside the rising Korean won to the US dollar exchange rat...
Oct 14, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom expands business portfolio with quantum tech
South Korea’s top mobile carrier SK Telecom Co. is expanding its business portfolio with quantum technology, even into industries that are unr...
Sep 20, 2022 (Gmt+09:00)
-
Bio & Pharma
Biden’s move to beef up US bio industry poses threat to Korean firms
President Joe Biden’s plan to support the US biomanufacturing infrastructure aimed at containing China’s clout is posing a threat to Sou...
Sep 14, 2022 (Gmt+09:00)
-
Bio & Pharma
Precision Biosensor enters Italy with chemical test kits
South Korea’s diagnostic devices supplier Precision Biosensor Inc. has signed an export contract with Italian medical device company Borden Ch...
Sep 01, 2022 (Gmt+09:00)
-
Fiber & Textile
Hyosung showcases world’s first bio spandex at Seoul textile exhibition
Hyosung TNC Corp., a South Korean textile and yarn maker, is showcasing the world’s first commercialized plant-based spandex at an internation...
Aug 24, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean bio firms look to pills, patches for people who fear needles
Getting shots of a drug or vaccine over a long period is not easy for many people.That's probably why global biopharmaceutical companies and biotech...
Aug 24, 2022 (Gmt+09:00)
-
Bio & Pharma
K-bio firms embrace gene therapy CDMO as Samsung looks the other way
South Korea’s major biopharmaceutical companies are rapidly embracing the cell and gene therapy business under a contract drug-making mechanis...
Aug 05, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Discovery to control affiliates’ entire biotechnology business
SK Discovery Co., an intermediate holding company of South Korea’s third-largest conglomerate SK Group, will take charge of the entire biotech...
Aug 05, 2022 (Gmt+09:00)
-
Bio & Pharma
Orion enters China’s vaccine market with tuberculosis plant in Jining
Orion Holdings Corp., one of South Korea’s largest confectionery companies, said on Wednesday it will build a vaccine plant in China by 2024 t...
Jul 13, 2022 (Gmt+09:00)
language -
Bio & Pharma
Korean biotech L&C Bio issues convertible bonds worth $46 mn
South Korean biotech company L&C Bio, which specializes in tissue regeneration treatment, is poised to ramp up its expansion into the Chinese ma...
Jun 30, 2022 (Gmt+09:00)
language -
Bio & Pharma
Lotte plans to expand bio capacity in Korea and US
Lotte Group is preparing to kickstart its biopharmaceutical business as a contract development and manufacturing company (CDMO) by building a new pl...
Jun 16, 2022 (Gmt+09:00)
language -
Bio & Pharma
Korean bio firms flock to US as SV Invest eyes $100 million bio fund
SV Investment, a South Korean venture capital and private equity firm, is looking to launch a $100 million bio fund in the US as a growing number of...
Jun 13, 2022 (Gmt+09:00)
language -
Bio & Pharma
Samsung Biologics signs $81 mn CMO deal with Novartis
South Korea’s Samsung Biologics Co. has inked an $81 million contract manufacturing deal with Novartis, the world’s fifth-largest pharma...
Jun 07, 2022 (Gmt+09:00)
language -
Behind the Scenes
Samsung in do-or-die race with $355 bn spending plan
"It's not a matter of numbers, but a matter of do or die for us."This is the first public remark from Samsung Electronics Co. Vice Chairman and de f...
May 26, 2022 (Gmt+09:00)
language -
Corporate investment
SK takes aim at chips, batteries, bio with $195 billion investment
SK Group, South Korea’s second-largest conglomerate after Samsung, on Thursday announced a plan to invest 247 trillion won ($195 billion) in k...
May 26, 2022 (Gmt+09:00)
language -
Corporate investment
Bio, mobility to top Lotte's $30 bn spending list by 2026
South Korea’s Lotte Group will spend a total of 37 trillion won ($29 billion) on its businesses over the next five years, a chunk of which wil...
May 25, 2022 (Gmt+09:00)
language -
Corporate investment
Samsung to invest $355 billion in chip, biotech, 6G over five years
South Korea’s top conglomerate Samsung has unveiled a plan to invest 450 trillion won ($355 billion) over the next five years in strategic sec...
May 24, 2022 (Gmt+09:00)
language -
Carbon neutrality
Hyundai Oilbank steps up eco-friendly white bio business
Hyundai Oilbank Co., a South Korean petroleum and refinery company, is slated to tap into the white biotechnology market. The company has selected w...
May 11, 2022 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand